Generation of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 gene

Stem Cell Res. 2021 Apr:52:102228. doi: 10.1016/j.scr.2021.102228. Epub 2021 Feb 10.

Abstract

Bartter Syndrome (BS) is a group of rare inherited autosome-recessive disease, which can be caused by the gene mutations of sodium-potassium-chloride cotransporter gene (SLC12A1). Here, the urine cells (UCs) derived from a 4-year-old female BS patient with the homozygote SLC12A1 gene mutation p.A244D (c.731C>A) were reprogramming into induced pluripotent stem cells (iPSCs) named WMUi019-A using a commercial Sendai virus reprogramming kit. The pluripotent stem cell markers like OCT4 and SSEA4 can be positively expressed in this iPSC line, which can also be induced to differentiate into three germ layers in vitro and maintain a stable karyotype (46, XY).

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bartter Syndrome*
  • Cell Differentiation
  • Child, Preschool
  • Female
  • Homozygote
  • Humans
  • Induced Pluripotent Stem Cells*
  • Mutation / genetics
  • Sendai virus
  • Solute Carrier Family 12, Member 1

Substances

  • SLC12A1 protein, human
  • Solute Carrier Family 12, Member 1